Metformin inhibits PPARδ agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cells-Reference-Cited by-同舟云学术

Metformin inhibits PPARδ agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cells

Published:2019-08 Issue: Volume:857 Page:172425
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Ding Jiajun,Gou Qian,Jin Jianhua,Shi Juanjuan,Liu Qian,Hou Yongzhong

Funder

National Natural Science Foundation of China

Changzhou Sci & Tech Program

Wujin Sci & Tech Program

Postdoctoral Science Foundation of Jiangsu Province

Publisher

Elsevier BV

Subject

Pharmacology

Reference39 articles.

1. Facile development, characterization, and optimization of new metformin-loaded nanocarrier system for efficient colon cancer adjunct therapy;Arafa;Drug Dev. Ind. Pharm.,2018

2. AMP-activated protein kinase fortifies epithelial tight junctions during energetic stress via its effector GIV/Girdin;Aznar;Elife,2016

3. Metabolic pathways promoting cancer cell survival and growth;Boroughs;Nat. Cell Biol.,2015

4. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate;Dang;Nature,2009

5. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis;Decensi;Cancer Prev. Res.,2010

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression;Clinical Nutrition;2024-02

2. Real-time monitoring of glucose metabolism and effects of metformin on HepG2 cells using 13C in-cell NMR spectroscopy;Biochemical and Biophysical Research Communications;2024-01

3. The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy;Frontiers in Pharmacology;2023-05-12

4. Expression of glucose transporter-1 in follicular lymphoma affected tumor-infiltrating immunocytes and was related to progression of disease within 24 months;Translational Oncology;2023-02

5. Three-Dimensional Microtumor Formation of Infantile Hemangioma-Derived Endothelial Cells for Mechanistic Exploration and Drug Screening;Pharmaceuticals;2022-11-12